Independent proposal for Real Chemistry · Pilot 1 concept
See the opportunity before it becomes an ordinary pursuit.
Inflection Radar proposes a way to turn permitted public evidence into a human-reviewed portfolio of emerging neuropsychiatry companies for internal consideration—without requiring production integration or internal data.
Pilot 1 identifies companies that appear externally attractive for Real Chemistry review. It does not decide which companies Real Chemistry should pursue.
Pilot 1 can answer
Which companies warrant internal review?
Public evidence · external opportunity score · source-linked dossiers · human portfolio decision
Company inclusion, interpretation, scoring overrides, escalation, prioritization, distribution
Interactive decision room
Test the method rather than taking it on faith.
This illustrative company is not a real recommendation. Change the weights to see how the external score and review disposition respond.
Illustrative account
Aperture Neuro
74/ 100
Current dispositionADVANCE TO HUMAN REVIEW
Evidence strength and timing currently drive the result.
Sample dossier
Evidence before interpretation
Observed fact
Company announces Phase 2 initiation through a first-party release; trial registry record is present.
Analytical inference
A more complex stakeholder and evidence environment may be emerging.
Unresolved
Public evidence cannot establish an agency need, relationship, conflict, or pursuit.
Evidence tier
Corroborated finding
Sources
First-party release + ClinicalTrials.gov
Rights
Publicly accessible; link and limited extraction permitted for research
Contradiction review
No conflict found; registry status requires recheck before circulation
Human gate
Account review required before any disposition
Governance by design
Permission is a lifecycle, not a label.
Select a source class to trace what may happen from acquisition through retention. Derived intelligence does not shed its upstream restrictions.
Decision and use-case definition
Source acquisition
Rights and permissions
Data engineering and security
Retrieval and provenance
Analysis and model orchestration
Human validation and compliance
Output, action, and monitoring
Source approval
Record validation
Analytical approval
Account review
Distribution approval
Verified fact
Corroborated finding
Analytical inference
Hypothesis or early signal
Proposed eight-week execution
Each proposed week ends with a reviewable object.
Select a week to inspect the proposed activities, output, dependency, and gate. These are planned deliverables, not evidence of a completed pilot.
Capability fit
The proposed white space is an operating layer.
Public evidence supports nearly all ingredients. It does not publicly establish this exact upstream growth workflow. “Not publicly evidenced” never means “does not exist.”
Confirmed ingredients
ANATOMI ecosystem
Analytics & Insights
HealthGEO and ReputAI
Medical, communications, access, media
Growth and revenue leadership
Inflection RadarOrganizes external evidence around prospective-account review
Internally unknown
Prospect discovery workflow
Growth-facing ANATOMI use
Target-account score
Conflict and ownership routing
Outcome-linked learning
One system · distinct reading modes
Choose the object that fits the moment.
Each file has its own job. Preview the purpose and reading time before opening or downloading.
5–7 min
Executive brief
The decision, direct diligence responses, scope, boundaries, and immediate ask.